


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Recently Viewed
WEN
Wendys
TLYS
Tilly's Inc.
PCVX
Vaxcyte
LEGN
Legend Biotech Corporatio
TEVA
Teva Pharma
Most Trending
+8.98%
+0.05%
-2.88%
WEN
Wendys
$8.04
Strengths

Upgraded on attractively valued

Expands stock buyback program
Risk Analysis

Earnings are forecast to decrease
WEN Price Performance
$8.35 (-3.71%)
$8.63 (-6.84%)
$10.27 (-21.71%)
$14.34 (-43.93%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Has a Strong balance sheet

Earnings decline YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity

Expands stock buyback program
Future
Future

Earnings are forecast to decrease
![]()
WEN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
WEN Street Sentiment is unimpressive and have negative views on the near-term outlook
WEN has Low risk level

Average key support and resistance price levels
WEN
Wendys
8.04
-0.50%
TLYS
Tilly's Inc.
1.53
-0.65%
PCVX
Vaxcyte
54.71
+2.45%
LEGN
Legend Biotech Corporatio
18.73
-1.16%
TEVA
Teva Pharma
32.28
+0.44%
What is WEN current stock price?
What are WEN stock strengths?
What is WEN Risk Level?
What is WEN market cap and volume?
What is WEN current Stock IQ?
Should I buy WEN stock right now?
Is WEN a Strong Buy right now?
What does a 'Strong Buy' rating mean for WEN?
What does a 'Strong Sell' rating mean for WEN?
What factors influence WEN's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Recently Viewed
WEN
Wendys
TLYS
Tilly's Inc.
PCVX
Vaxcyte
LEGN
Legend Biotech Corporatio
TEVA
Teva Pharma
Most Trending
+8.98%
+0.05%
-2.88%
WEN
Wendys
Current Price
$8.04
Stock Insights
Strengths

Upgraded on attractively valued

Expands stock buyback program
Risk Analysis

Earnings are forecast to decrease
Recently Viewed
WEN
Wendys
8.04
-0.50%
TLYS
Tilly's Inc.
1.53
-0.65%
PCVX
Vaxcyte
54.71
+2.45%
LEGN
Legend Biotech Corporatio
18.73
-1.16%
TEVA
Teva Pharma
32.28
+0.44%

WEN Price Performance
$8.35 (-3.71%)
$8.63 (-6.84%)
$10.27 (-21.71%)
$14.34 (-43.93%)
WEN Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Has a Strong balance sheet

Earnings decline YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity

Expands stock buyback program
Future
Future

Earnings are forecast to decrease
![]()
WEN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
WEN Street Sentiment is unimpressive and have negative views on the near-term outlook
WEN has Low risk level

Average key support and resistance price levels
Overall Wall Street Rating
STRONG SELL
Dec 18, 2025
Reiterate
Sell
Goldman Sachs
Nov 11, 2025
Reiterate
Neutral
UBS
Nov 10, 2025
Reiterate
Hold
TD Cowen
Oct 21, 2025
Reiterate
Sell
Goldman Sachs
WEN Stock IQ
WEN Latest Analysis
AIxCrypto Co-CEO Jerry Wang Shares Weekly Investor Update: Crypto Flywheel Growth. ".The velocity of business here in the MENA region is remarkable. While my current travel schedule in This week we made meaningful progress across talent community and product.1. Global Hiring InitiatedWith AIxC Hub user growth exceeding expectations we are accelerating our strategic talent expansion to match the pace of the business.We are actively hiring four key roles: Communications Manager Growth Operator
Today
Wendys Rolls Out New Biggie Deals Menu Across US Restaurants . (RTTNews) - The Wendys Company (WEN) Wednesday announced the launch of a new Biggie Deals menu with the choice of $4 Biggie Bites $6 Biggie Bag and $8 Biggie Bundle.
Wed Jan 14, 2026
Looking Into The Wendys Cos Recent Short Interest. ) short interest as a percent of float has fallen 7.82% since its last report. According to exchange reported data there are now Short interest is the number of shares that have been sold short but have not yet been covered or closed out. is when a trader sells shares of a company they do not own with the hope that the price will ...
Fri Jan 9, 2026
Analysts Cautious on The Wendys Company (WEN) Amid Cost and Margin Pressures.
Thu Jan 8, 2026
The Wendys Company: Valuation Has Priced In The Weak Fundamentals (Rating Upgrade).
Thu Jan 8, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.